Evidence map›Paper›PMID 32585856›Full record

ArticleInternational journal of molecular sciences2020

YBX1 Indirectly Targets Heterochromatin-Repressed Inflammatory Response-Related Apoptosis Genes through Regulating CBX5 mRNA.

Andreas Kloetgen, Sujitha Duggimpudi, Konstantin Schuschel, Kebria Hezaveh, Daniel Picard, Heiner Schaal, Marc Remke, Jan-Henning Klusmann, Arndt Borkhardt, Alice C McHardy and 1 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
0.9field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed, 18 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. The Roles of H3K9me3 Writers, Readers, and Erasers in Cancer Immunotherapy.International journal of molecular sciences · 2024
    Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 2 countries.

Andreas KloetgenDepartment of Computational Biology of Infection Research, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany.
Sujitha DuggimpudiDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, 40225 Düsseldorf, Germany.
Konstantin SchuschelDepartment of Pediatrics 1, Martin Luther University Halle-Wittenberg, 06120 Halle, Germany.ORCID 0000-0002-5417-8950
Kebria HezavehDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, 40225 Düsseldorf, Germany.
Daniel PicardDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, 40225 Düsseldorf, Germany.
Heiner SchaalInstitute of Virology, Medical Faculty, Heinrich-Heine-University, 40225 Düsseldorf, Germany.ORCID 0000-0002-1636-4365
Marc RemkeDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, 40225 Düsseldorf, Germany.
Jan-Henning KlusmannDepartment of Pediatrics 1, Martin Luther University Halle-Wittenberg, 06120 Halle, Germany.ORCID 0000-0002-1070-0727
Arndt BorkhardtDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, 40225 Düsseldorf, Germany.ORCID 0000-0002-6121-4737
Alice C McHardyDepartment of Computational Biology of Infection Research, Helmholtz Centre for Infection Research, 38124 Braunschweig, Germany.
Jessica I HoellDepartment of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, 40225 Düsseldorf, Germany.
Heinrich Heine University Düsseldorf · DEHelmholtz Centre for Infection Research · DEMartin Luther University Halle-Wittenberg · DEUniversity Health Network · CA

Funding

Deutsche Forschungsgemeinschaft HO 5456/3-1European Research Council 714226
6 · The paper itself

Abstract

Medulloblastomas arise from undifferentiated precursor cells in the cerebellum and account for about 20% of all solid brain tumors during childhood; standard therapies include radiation and chemotherapy, which oftentimes come with severe impairment of the cognitive development of the young patients. Here, we show that the posttranscriptional regulator Y-box binding protein 1 (YBX1), a DNA- and RNA-binding protein, acts as an oncogene in medulloblastomas by regulating cellular survival and apoptosis. We observed different cellular responses upon YBX1 knockdown in several medulloblastoma cell lines, with significantly altered transcription and subsequent apoptosis rates. Mechanistically, PAR-CLIP for YBX1 and integration with RNA-Seq data uncovered direct posttranscriptional control of the heterochromatin-associated gene

Indexed as

Gene Expression Regulation, NeoplasticApoptosisBiomarkers, TumorCell ProliferationCerebellar NeoplasmsChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneHeterochromatinHumansInflammationMedulloblastomaRNA, MessengerTumor Cells, CulturedY-Box-Binding Protein 1Biomarkers, TumorCBX5 protein, humanChromobox Protein Homolog 5Chromosomal Proteins, Non-HistoneHeterochromatinRNA, MessengerY-Box-Binding Protein 1YBX1 protein, humanmedulloblastomaPAR-CLIPpost-transcriptional gene regulationRNA-SeqY-box binding protein 1

Identifiers

PMID32585856
PMCPMC7352269
OpenAlexW3036697998

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.